Vibro-Acoustography Imaging in Finding Breast Microcalcifications and Lesions in Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00626119
Recruitment Status : Completed
First Posted : February 29, 2008
Last Update Posted : June 21, 2012
National Cancer Institute (NCI)
Information provided by:
Mayo Clinic

Brief Summary:

RATIONALE: New diagnostic procedures, such as vibro-acoustography imaging, may be an effective method of finding microcalcifications and lesions in the breast.

PURPOSE: This clinical trial is studying how well vibro-acoustography imaging works in finding breast microcalcifications and lesions in women.

Condition or disease
Breast Cancer

Detailed Description:


  • To further develop a new method of in vivo imaging of the breast using vibro-acoustography (VA) imaging.
  • To demonstrate and evaluate the capability of VA imaging in detecting microcalcifications and lesions inside the human breast.

OUTLINE: Participants undergo vibro-acoustography (VA) imaging of the breast using ultrasonography over 90 minutes. Participants may also undergo further imaging using clinical ultrasonography.

Study Type : Observational
Actual Enrollment : 34 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: In Vivo Breast Imaging by Vibro-acoustography
Study Start Date : June 2001
Actual Primary Completion Date : February 2012
Actual Study Completion Date : February 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources


Primary Outcome Measures :
  1. Further development of a new method of in vivo imaging of the breast using vibro-acoustography (VA) imaging [ Time Frame: one day ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
patients with and without breast masses


  • Meets one of the following criteria:

    • Healthy participant
    • Proven microcalcifications and/or lesions in the breast
  • Hormone status not specified


  • Female
  • Menopausal status not specified
  • Not pregnant or nursing
  • No condition that does not allow proper use of study imaging devices


  • Not specified

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00626119

United States, Minnesota
Mayo Clinic Cancer Center
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
National Cancer Institute (NCI)
Principal Investigator: Mostafa Fatemi, PhD Mayo Clinic

Responsible Party: Mostafa Fatemi, PhD, Mayo Clinic Identifier: NCT00626119     History of Changes
Other Study ID Numbers: 729-01-0
P30CA015083 ( U.S. NIH Grant/Contract )
CDR0000583249 ( Registry Identifier: NCI )
First Posted: February 29, 2008    Key Record Dates
Last Update Posted: June 21, 2012
Last Verified: June 2012

Keywords provided by Mayo Clinic:
breast cancer